Literature DB >> 21625759

Odors as triggering and worsening factors for migraine in men.

Andressa Marmore de Lima1, Giovanna Baptista Sapienza, Vinícius de Oliveira Giraud, Yára Dadalti Fragoso.   

Abstract

OBJECTIVE: To assess the role of odors in triggering or worsening migraine in men.
METHOD: Ninety-eight male migraineurs from the general population were assessed individually through questionnaires. Environmental factors relating to their migraine were reported, with special focus on the role of odors.
RESULTS: Odors were the second most frequent triggering factor for migraine attacks (48%), behind stressful situations (59%). Likewise, odors were the second most frequent worsening factor (73%), just behind excessive light (74%). Thirty-three individuals (33.4%) stated that odors were both triggering and worsening factors for their migraine attacks. Perfume, cigarette smoke and cleaning products were the most frequent migraine-related odors reported by these male migraineurs.
CONCLUSION: This was the first study to assess the role of odors in migraine exclusively in men. There was a high degree of odor-related migraine among these men, thus suggesting that patient education could alert such individuals to gender-related factors, since different triggering and worsening factors have been reported by males and females.

Entities:  

Mesh:

Year:  2011        PMID: 21625759     DOI: 10.1590/s0004-282x2011000300011

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  14 in total

Review 1.  Migraine and triggers: post hoc ergo propter hoc?

Authors:  Jan Hoffmann; Ana Recober
Journal:  Curr Pain Headache Rep       Date:  2013-10

Review 2.  The TRPA1 channel in migraine mechanism and treatment.

Authors:  S Benemei; C Fusi; Gabriela Trevisan; Pierangelo Geppetti
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

3.  Activation of TRPA1 on dural afferents: a potential mechanism of headache pain.

Authors:  Rebecca M Edelmayer; Larry N Le; Jin Yan; Xiaomei Wei; Romina Nassini; Serena Materazzi; Delia Preti; Giovanni Appendino; Pierangelo Geppetti; David W Dodick; Todd W Vanderah; Frank Porreca; Gregory Dussor
Journal:  Pain       Date:  2012-07-17       Impact factor: 6.961

Review 4.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

5.  Olfactory bulbus volume and olfactory sulcus depth in migraine patients: an MRI evaluation.

Authors:  Adil Doğan; Nuray Bayar Muluk; Mehmet Hamdi Şahan; Neşe Asal; Mikail Inal; Ufuk Ergün
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-06       Impact factor: 2.503

6.  Prevalence and characteristics of migraine in medical students and its impact on their daily activities.

Authors:  Bindu Menon; Neeharika Kinnera
Journal:  Ann Indian Acad Neurol       Date:  2013-04       Impact factor: 1.383

Review 7.  The Prevalence of Migraine in Iran: A Systematic Review and Meta-Analysis.

Authors:  Zeynab Farhadi; Saeideh Alidoost; Meysam Behzadifar; Roghayeh Mohammadibakhsh; Najmeh Khodadadi; Razieh Sepehrian; Rahim Sohrabi; Masood Taheri Mirghaed; Morteza Salemi; Hamid Ravaghi; Masoud Behzadifar
Journal:  Iran Red Crescent Med J       Date:  2016-09-21       Impact factor: 0.611

Review 8.  TRPA1 and other TRP channels in migraine.

Authors:  Silvia Benemei; Francesco De Cesaris; Camilla Fusi; Eleonora Rossi; Chiara Lupi; Pierangelo Geppetti
Journal:  J Headache Pain       Date:  2013-08-13       Impact factor: 7.277

9.  The role of the transient receptor potential ankyrin type-1 (TRPA1) channel in migraine pain: evaluation in an animal model.

Authors:  Chiara Demartini; Cristina Tassorelli; Anna Maria Zanaboni; Germana Tonsi; Oscar Francesconi; Cristina Nativi; Rosaria Greco
Journal:  J Headache Pain       Date:  2017-09-07       Impact factor: 7.277

10.  The effects of Maras powder use on patients with migraine.

Authors:  Yılmaz İnanç; Fatma Özlem Orhan; Yusuf İnanç
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-07       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.